Filed with ASX · · 4 pages · English
Biotron Limited has announced the commencement of Mr. Glenn Gilbert as Chief Executive Officer and Executive Director, effective immediately, ahead of his previously scheduled start date. Mr. Gilbert's immediate focus will be on reviewing the company's development portfolio and establishing priorities for its growth, particularly regarding the SedRx anaesthetic project. The filing includes an Initial Director’s Interest Notice, indicating that Mr. Gilbert currently holds no securities in the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
NEW BIOTRON CEO COMMENCES Highlights: • Biotron CEO and Executive Director Glenn Gilbert has commenced, bringing forward his start date from January 2027. • Mr Gilbert brings extensive experience across clinical and regulatory development, manufacturing, commercialisation, business development...
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron